Effects of dapagliflozin on myocardial motion parameters and cardiac electrophysiology in patients with type 2 diabetes Mellitus and coronary heart disease - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Dapagliflozin on Cardiac Motion Metrics and Electrophysiological Function in Individuals with Type 2 Diabetes Mellitus and Coronary Artery Disease

  • By

  • Fang Liu

  • Rui Jin

  • June 4, 2026

Share

Original Source(s)

Effects of dapagliflozin on myocardial motion parameters and cardiac electrophysiology in patients with type 2 diabetes Mellitus and coronary heart disease

  • by Fang Liu, Rui Jin

  • June 4, 2026

Related Content

Editorial: Emerging technologies in imaging for pediatric heart conditions

Self-supervised representation learning reveals explainable physiological structure in high-dimensional magnetocardiography

Effectiveness and safety of Guipi Mixture for the treatment of premature ventricular contractions (heart-spleen deficiency syndrome): study protocol for a randomized, double-blind, placebo-controlled, multicentre trial